The stock of Asarfi Hospital, a key player in the hospital sector, recorded this fresh peak today, reflecting sustained momentum over the past year. This new high price stands in contrast to its 52-week low of Rs.72.9, illustrating a substantial price range within the last twelve months.
Over the last year, Asarfi Hospital's stock has delivered a return of 122.42%, significantly outpacing the Sensex's 9.72% return over the same period. This performance underscores the stock's relative strength within the broader market and its sector. The Sensex itself is trading close to its 52-week high, currently at 84,853.60, which is 0.51% shy of its peak of 85,290.06, indicating a generally positive market backdrop despite some volatility.
Today, Asarfi Hospital's stock underperformed its sector by 0.49%, with a day change of -1.65%. Notably, the stock has retreated after two consecutive days of gains, suggesting some short-term profit-taking following the recent rally. Despite this, the stock remains above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a strong upward trend in technical terms.
Handpicked from 50, scrutinized by experts – Our recent selection, this micro-cap from Hospital, is already delivering results. Don't miss next month's pick!
- Expert-scrutinized selection
- Already delivering results
- Monthly focused approach
Financially, Asarfi Hospital has demonstrated a strong ability to service its debt, with a Debt to EBITDA ratio of 1.44 times. This metric indicates a manageable level of leverage relative to earnings before interest, taxes, depreciation and amortisation. The company’s net profit growth of 34.38% in the most recent quarter further highlights its earnings momentum.
In terms of quarterly performance, the company reported its highest net sales at Rs.44.89 crores, alongside a peak PBDIT of Rs.8.87 crores and a PBT less other income of Rs.4.89 crores. These figures reflect a period of robust operational results contributing to the stock’s upward trajectory.
Asarfi Hospital’s return on capital employed (ROCE) stands at 8.6%, which, while modest, is accompanied by an enterprise value to capital employed ratio of 3.3. This valuation metric suggests an attractive relationship between the company’s market value and the capital it employs in its operations.
Over the past five years, the company’s operating profit has grown at an annual rate of 14.76%, indicating steady expansion in core profitability. However, the average ROCE of 8.67% points to relatively low profitability per unit of total capital, a factor that investors may consider when analysing the company’s efficiency.
Thinking about Asarfi Hospital ? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this micro-cap stock!
- Real-time Verdict available
- Financial health breakdown
- Fair valuation calculated
Institutional participation in Asarfi Hospital has seen a decline, with institutional investors reducing their stake by 1.04% in the previous quarter. Currently, these investors hold 2.24% of the company’s shares. This shift in shareholding may reflect changing evaluations of the stock’s fundamentals by larger market participants.
Despite the recent peak, the stock’s short-term movement shows some volatility, as evidenced by the slight pullback following the new high. The broader market context, with the Sensex trading above its 50-day moving average and maintaining a bullish technical stance, provides a supportive environment for stocks like Asarfi Hospital.
In summary, Asarfi Hospital’s attainment of a new 52-week high at Rs.193.8 marks a key milestone in its stock journey, supported by strong financial metrics and sustained price momentum. The stock’s performance over the past year has been notably robust relative to market benchmarks, reflecting a combination of operational results and market dynamics within the hospital sector.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
